TY - JOUR
T1 - Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan
T2 - a population-based prospective cohort study
AU - For the Japan Public Health Center-based Prospective Study Group
AU - Matsuoka, Y. J.
AU - Sawada, N.
AU - Mimura, M.
AU - Shikimoto, R.
AU - Nozaki, S.
AU - Hamazaki, K.
AU - Uchitomi, Y.
AU - Tsugane, S.
N1 - Funding Information:
YJM has received a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, an intramural research grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry Japan (27-3-2), and a grant from Pfizer Health Research Foundation and SENSHIN Medical Research Foundation. MM has received grants and/or speaker’s honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Kracie, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda Yakuhin, Tanabe Mitsubishi Pharma and Yoshitomi Yakuhin within the last 3 years. KH has received a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, an intramural research grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry Japan (27-3-2), and a grant for research activities of First Bank of Toyama Scholarship Foundation. YU has received a research grant for Promotion of Cancer Control Programmes (H26-political-general-002) and The National Cancer Center Research and Development Fund (27-A-3). The remaining authors declare no conflicts of interest.
Publisher Copyright:
© The Author(s) 2017.
PY - 2017
Y1 - 2017
N2 - Systematic review of observational studies has revealed that fish consumption and levels of n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid are associated with a reduced risk of depression. A reverse J-shaped effect of n-3 PUFAs was suggested. However, there is limited evidence from populations with high fish consumption and no studies have used a standard psychiatrist-based diagnosis of major depressive disorder (MDD). Therefore, this population-based, prospective study investigated the association of dietary fish, n-3 PUFA, and n-6 PUFA consumption with risk of psychiatrist-diagnosed MDD in Japan. A total of 12 219 subjects were enrolled from the Saku area in 1990. Of these, we extracted 1181 participants aged 63–82 years who completed food frequency questionnaires in both 1995 and 2000 and also underwent a mental health examination in 2014–2015. Odds ratios (ORs) and 95% confidence intervals (CIs) for MDD according to fish intake and PUFA quartiles were calculated. Current MDD was diagnosed in 95 patients. We found a reduced risk of MDD in the third quartile for fish intake (111.1 g per day, OR = 0.44, 95% CI = 0.23–0.84), second quartile for EPA (307.7 mg per day, OR = 0.54, 95% CI = 0.30–0.99) and third quartile for docosapentaenoic acid (DPA) (123.1 mg per day, OR = 0.42, 95% CI = 0.22–0.85). ORs adjusted for cancer, stroke, myocardial infarction and diabetes remained significant for fish and DPA intake. Our results suggest that moderate fish intake could be recommended for the prevention of MDD in aged Japanese individuals.
AB - Systematic review of observational studies has revealed that fish consumption and levels of n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid are associated with a reduced risk of depression. A reverse J-shaped effect of n-3 PUFAs was suggested. However, there is limited evidence from populations with high fish consumption and no studies have used a standard psychiatrist-based diagnosis of major depressive disorder (MDD). Therefore, this population-based, prospective study investigated the association of dietary fish, n-3 PUFA, and n-6 PUFA consumption with risk of psychiatrist-diagnosed MDD in Japan. A total of 12 219 subjects were enrolled from the Saku area in 1990. Of these, we extracted 1181 participants aged 63–82 years who completed food frequency questionnaires in both 1995 and 2000 and also underwent a mental health examination in 2014–2015. Odds ratios (ORs) and 95% confidence intervals (CIs) for MDD according to fish intake and PUFA quartiles were calculated. Current MDD was diagnosed in 95 patients. We found a reduced risk of MDD in the third quartile for fish intake (111.1 g per day, OR = 0.44, 95% CI = 0.23–0.84), second quartile for EPA (307.7 mg per day, OR = 0.54, 95% CI = 0.30–0.99) and third quartile for docosapentaenoic acid (DPA) (123.1 mg per day, OR = 0.42, 95% CI = 0.22–0.85). ORs adjusted for cancer, stroke, myocardial infarction and diabetes remained significant for fish and DPA intake. Our results suggest that moderate fish intake could be recommended for the prevention of MDD in aged Japanese individuals.
UR - http://www.scopus.com/inward/record.url?scp=85047309618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047309618&partnerID=8YFLogxK
U2 - 10.1038/TP.2017.206
DO - 10.1038/TP.2017.206
M3 - Article
C2 - 28949340
AN - SCOPUS:85047309618
SN - 2158-3188
VL - 7
JO - Translational psychiatry
JF - Translational psychiatry
IS - 9
M1 - e1242
ER -